hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06287190 id: Self-confidence assessment briefTitle: Assessment of Self-Confidence of Dental Interns Regarding Provision of Different Pediatric Dentistry Procedures overallStatus: NOT_YET_RECRUITING date: 2024-03-01 date: 2024-09-30 date: 2024-11-30 date: 2024-03-01 date: 2024-03-05 name: Cairo University class: OTHER briefSummary: This study mainly about dental interns testing their knowledge before and after entering the pediatric rotation conditions: Self Confidence studyType: OBSERVATIONAL observationalModel: OTHER timePerspective: PROSPECTIVE count: 383 type: ESTIMATED name: Dental interns measure: Self-confidence regarding treatment measure: difficulties in dental practice through this period sex: ALL stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: Cairo University city: Cairo country: Egypt name: Sherine E Eldin, Prof role: CONTACT phone: +20 1009073142 lat: 30.06263 lon: 31.24967 hasResults: False
nctId: NCT06287177 id: Protocol 28/2023 briefTitle: Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy acronym: CHOLINET overallStatus: RECRUITING date: 2022-11-01 date: 2024-02-29 date: 2024-11-01 date: 2024-02-29 date: 2024-03-19 name: Federico II University class: OTHER briefSummary: Evaluation of adherence, persistence and efficacy of treatment with Inclisiran in a real-life Italian population conditions: Hypercholesterolemia studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 1000 type: ESTIMATED name: Inclisiran measure: Description of adherence to treatment with Inclisiran in a real-life Italian population measure: Description of persistence to treatment with Inclisiran in a real-life Italian population measure: Description of efficacy of treatment with Inclisiran in a real-life Italian population sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Federico II University of Naples, Department of Advanced Biomedical Sciences status: RECRUITING city: Napoli zip: 80131 country: Italy name: Pasquale Perrone Filardi, MD role: CONTACT phone: 0817462224 email: fpperron@unina.it lat: 40.85216 lon: 14.26811 hasResults: False
nctId: NCT06287164 id: 101 briefTitle: Management of Heart Failure in Italian Outpatients Clinics: Observational Study acronym: OPTIMA-HF overallStatus: RECRUITING date: 2023-03-01 date: 2024-02-01 date: 2025-02-01 date: 2024-02-29 date: 2024-02-29 name: Federico II University class: OTHER briefSummary: OPTIMA-HF is an observational, cross-sectional, multicenter, real-life study conducted in two different clinical settings: HF outpatients' clinics of Italian University Hospitals and territorial Cardiology outpatients' services.
Aim of the Optimization of Therapy in the Italian Management of Heart Failure \[OpTIMa-HF\] Registry is to collect data on HF patients followed in different Italian outpatients' settings to describe the current Italian population of HF patients, in terms of demographic characteristics and disease features, with a specific focus on guideline-directed medical therapy (GDMT) prescription, assessing its improvement after educational activities. In the present analysis we report the baseline data on the general enrolled population with a specific focus on HFrEF treatment adherence and prescription rates, according to the most recent European Guidelines. conditions: Heart Failure studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 4000 type: ESTIMATED name: Data collection measure: HF treatment adherence according to the most recent European Guidelines sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Federico II University of Naples, Department of Advanced Biomedical Sciences status: RECRUITING city: Napoli zip: 80131 country: Italy name: Pasquale Perrone Filardi, MD role: CONTACT phone: 0817462224 email: fpperron@unina.it lat: 40.85216 lon: 14.26811 hasResults: False
nctId: NCT06287125 id: Renal assess in SSc and SLE briefTitle: Renal Assessment for Early Detection of Renal Impairment in Systemic Sclerosis and Systemic Lupus Erythematosus Patients overallStatus: NOT_YET_RECRUITING date: 2024-03-01 date: 2026-03-01 date: 2027-03-01 date: 2024-02-29 date: 2024-02-29 name: Assiut University class: OTHER briefSummary: * Evaluate renal resistive index in SSc and SLE patients for early detection of renal impairment.
* Correlation between detected markers and other assessment tools. conditions: Systemic Sclerosis and Systemic Lupus Erythematous studyType: OBSERVATIONAL observationalModel: CASE_CONTROL timePerspective: PROSPECTIVE count: 95 type: ESTIMATED name: Renal multi-parametric MRI, Renal doppler ultrasound, Serum CD147 measure: Evaluate serum levels of CD147 in SSc and SLE patients measure: Evaluate renal resistive index in SSC and SLE patients measure: Evaluate Multiparametric MRI in SSC and SLE measure: Utility of CD 147 in ssc and SLE patients measure: Utility of renal resistive index in SSC and SLE patients measure: Utility of Multiparametric MRI in SSC and SLE sex: ALL minimumAge: 18 Years maximumAge: 70 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06287112 id: PAC-ETGBD briefTitle: Prevention of Acute Cholecystitis With ETGBD overallStatus: NOT_YET_RECRUITING date: 2024-03-02 date: 2025-02-20 date: 2025-03-30 date: 2024-02-29 date: 2024-02-29 name: Seoul National University Hospital class: OTHER briefSummary: The goal of this clinical trial is to learn about Efficacy of the ETGBD parallel insertion with fully covered self-expandable metal stent for preventing acute cholecystitis in patients with low cystic duct insertion.
In this study, we hypothesized that endoscopic transpapillary gallbladder drainage (ETGBD) with parallel insertion of a fully covered self-expanding metal stent(FCSEMS) through an endoscopic biliary drainage tunnel is superior in preventing complications such as cholecystitis when the gallbladder ducts confluence within the distal third of the common bile duct. And we aimed to confirm its efficacy by comparing the frequency, severity, and rate of invasive additional procedures due to cholecystitis complications to provide evidence of clinical utility. conditions: Biliary Obstruction conditions: Acute Cholecystitis studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: PREVENTION masking: NONE count: 35 type: ESTIMATED name: Endoscopic transpapillary gallbladder drainage (ETGBD) measure: Incidence rate of acute cholecystitis sex: ALL minimumAge: 19 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06287099 id: 2023-BRL-101-SCD briefTitle: Clinical Study of BRL-101 in the Treatment of Sickle Cell Disease overallStatus: NOT_YET_RECRUITING date: 2024-04-20 date: 2025-10-20 date: 2026-05-10 date: 2024-02-29 date: 2024-03-19 name: Bioray Laboratories class: INDUSTRY name: Nanfang Hospital, Southern Medical University briefSummary: This is a single center, non-randomized, open label, single-dose study in subjects with Sickle Cell Disease (SCD). The study will evaluate the safety and efficacy of autologous CRISPR-Cas9 modified CD34+ human hematopoietic stem and progenitor cells (hHSPCs) (BRL-101). conditions: Sickle Cell Disease studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 5 type: ESTIMATED name: BRL-101 measure: Proportion of stem cell engrafted subjects measure: Time to neutrophil engraftment measure: Frequency, severity, and relationship to BRL-101 of adverse events over 12 months following BRL-101 infusion. sex: ALL minimumAge: 3 Years maximumAge: 35 Years stdAges: CHILD stdAges: ADULT hasResults: False
nctId: NCT06287086 id: 2024-BRL-101-SCD briefTitle: Clinical Study on the Safety and Efficacy of BRL-101 in the Treatment of Sickle Cell Disease overallStatus: NOT_YET_RECRUITING date: 2024-05-14 date: 2025-08-20 date: 2026-06-10 date: 2024-02-29 date: 2024-03-12 name: Bioray Laboratories class: INDUSTRY name: Chinese Academy of Medical Sciences briefSummary: This is a single center, non-randomized, open label, single-dose study in subjects with Sickle Cell Disease (SCD). The study will evaluate the safety and efficacy of autologous CRISPR-Cas9 modified CD34+ human hematopoietic stem and progenitor cells (hHSPCs) (BRL-101) conditions: Sickle Cell Disease studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 1 type: ESTIMATED name: BRL-101 autologous hematopoietic stem and progenitor cells injection measure: Proportion of stem cell engrafted subjects measure: Time to neutrophil engraftment measure: Frequency, severity, and relationship to BRL-101 of adverse events over 12 months following BRL-101 infusion.. sex: ALL minimumAge: 3 Years maximumAge: 35 Years stdAges: CHILD stdAges: ADULT hasResults: False
nctId: NCT06287073 id: 1245-0323 id: EUPAS107293 type: REGISTRY domain: EU PAS Register briefTitle: JARDIANCE® Post Marketing Surveillance in Korean Patients With Chronic Kidney Disease (CKD) overallStatus: RECRUITING date: 2024-03-29 date: 2025-08-18 date: 2025-11-22 date: 2024-02-29 date: 2024-04-23 name: Boehringer Ingelheim class: INDUSTRY briefSummary: The primary objective is to monitor the safety profile of JARDIANCE® in Korean patient with chronic kidney disease (CKD) in routine clinical practice.
The secondary objective is to monitor the efficacy of JARDIANCE® by evaluating changes in urine albumin-creatinine ratio (UACR) after 12 and/or 24 weeks of treatment. conditions: Kidney Disease, Chronic studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 600 type: ESTIMATED name: JARDIANCE® measure: Number of subjects with adverse events measure: Number of subjects with serious adverse event measure: Number of subjects with non-serious adverse events measure: Number of subjects with adverse drug reaction measure: Number of subjects with serious adverse drug reactions measure: Number of subjects with unexpected adverse events measure: Number of subjects with adverse events of special interest measure: Number of subjects with specific adverse events measure: Number of subjects with adverse events leading to temporary or permanent discontinuation measure: Number of subjects with adverse events by intensity measure: Number of subjects with adverse events by outcome of the events measure: Number of subjects with adverse events by causality measure: Number of subjects with adverse events leading to death measure: Occurrence of change in urine albumin-creatinine ratio (UACR) from baseline after 12 weeks and/or 24 weeks of treatment sex: ALL minimumAge: 19 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Samsung Medical Center status: RECRUITING city: Seoul zip: 03181 country: Korea, Republic of name: Boehringer Ingelheim role: CONTACT phone: 0808802084 email: namhan@bitrialsupport.com lat: 37.566 lon: 126.9784 hasResults: False
nctId: NCT06287060 id: Strawberry extract briefTitle: Bleaching Effect of Strawberry Extract Versus Hydrogen Peroxide in Patients With Extrinsic Staining overallStatus: NOT_YET_RECRUITING date: 2024-07 date: 2024-12 date: 2024-12 date: 2024-02-29 date: 2024-02-29 name: Cairo University class: OTHER briefSummary: with limited evidence based information in literature about using Strawberry extract for teeth bleaching in patients with extrinsic staining , it is beneficial to evaluate this new material using a randomized controlled clinical trial to test the null hypothesis that this extract will have the same effect as Hydrogen peroxide regarding the bleaching effect and hypersensitivity. conditions: Bleaching Effect and Postoperative Sensitivity of Strawberry Extract studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: DOUBLE whoMasked: PARTICIPANT whoMasked: OUTCOMES_ASSESSOR count: 40 type: ESTIMATED name: strawberry extract. measure: Bleaching effect of strawberry extract versus Hydrogen peroxide. measure: post operative sensitivity. sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06287047 id: spinal needle sizes and DPE briefTitle: The Impact of Using Different Spinal Needle Sizes on the Efficacy of the Dural Puncture Epidural Block overallStatus: ACTIVE_NOT_RECRUITING date: 2021-01-01 date: 2022-01-31 date: 2024-04-15 date: 2024-02-29 date: 2024-03-19 name: Cairo University class: OTHER briefSummary: The aim of this study is to compare the dural puncture epidural technique (DPET) with either 25-gauge spinal needle or 27-gauge spinal needle versus conventional epidural technique and evaluate whether DPET improves onset and spread of labor analgesia and if there is a role of the usage of different sized needles as regards block efficiency and complications. conditions: Dural Puncture Epidural Technique studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: 81 patients meeting the inclusion criteria will be randomly divided into three equal groups: Group A (n=27): Conventional epidural. Group B (n=27): Dural puncture epidural with 25-gauge spinal needle. Group C (n=27): Dural puncture epidural with 27-gauge spinal needle. primaryPurpose: OTHER masking: DOUBLE maskingDescription: The details of the series will be unknown to the investigators and the group assignment will be kept in asset of sealed envelopes each bearing only the case number on the outside. Prior to surgery the appropriate numbered envelope will be opened by the nurse, the card inside will determine the patient group. whoMasked: PARTICIPANT whoMasked: INVESTIGATOR count: 81 type: ACTUAL name: Epidural analgesia measure: Onset of analgesia measure: Degree of analgesia sex: FEMALE minimumAge: 18 Years maximumAge: 45 Years stdAges: ADULT facility: Faculty of Medidcne, Cairo Univerisity city: Cairo country: Egypt lat: 30.06263 lon: 31.24967 hasResults: False
nctId: NCT06287034 id: RS1833/23 briefTitle: The Role of the Free/Pedunculated Flap in Total Laryngectomy After (Chemo-)Radiotherapy Failure for Laryngeal Carcinoma: Impact on the Risk of Pharyngocutaneous Fistula (PCF) overallStatus: RECRUITING date: 2023-03-21 date: 2025-03-21 date: 2025-09-21 date: 2024-02-29 date: 2024-02-29 name: Regina Elena Cancer Institute class: OTHER briefSummary: Multicenter, prospective, randomized study aimed at evaluating the difference in risk of PCF after salvage laryngectomy in two groups of patients: one cohort treated with Total Laryngectomy (LT) with primary suture, a second group treated with LT and reinforcement by flap positioning with onlay technique (PMM, ALT) conditions: Larynx Carcinoma studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 102 type: ESTIMATED name: Primary suture measure: questionnaires for evaluation of the quality of life measure: Identification of risk factors measure: Evaluation of swallowing function measure: Evaluation of vocal rehabilitation sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: "Regina Elena" National Cancer Institute status: RECRUITING city: Rome zip: 00144 country: Italy name: Pellini Raul, Doctor role: CONTACT phone: 06-52664484 email: raul.pellini@ifo.it lat: 41.89193 lon: 12.51133 hasResults: False
nctId: NCT06287021 id: TRASERBMD2022 briefTitle: Bone Remodeling Around a Trabecular Titanium Cup in Total Hip Arthroplasty overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2027-02 date: 2027-02 date: 2024-02-29 date: 2024-04-03 name: Permedica spa class: INDUSTRY briefSummary: The goal of this randomized controlled trial is to measure the periprosthetic bone mineral density changes around a 3D-printed highly-porous titanium acetabular cup used in primary total hip arthroplasty compared to a standard hydroxyapatite/titanium plasma-sprayed acetabular cup up to 2-year follow-up. conditions: Total Hip Arthroplasty studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Controlled, randomized, unblinded, multicenter primaryPurpose: TREATMENT masking: NONE count: 50 type: ESTIMATED name: Jump System Traser® cup name: Jump System HAX-Pore® cup measure: BMD - ROI 1 measure: BMD - ROI 2,3,4 measure: Harris hip score measure: Moore's osseointegration signs sex: ALL minimumAge: 40 Years maximumAge: 85 Years stdAges: ADULT stdAges: OLDER_ADULT facility: IRCCS Istituto Clinico San Siro city: Milan zip: 20148 country: Italy name: Matteo Del Re, MD role: CONTACT email: matteodelre91@gmail.com lat: 45.46427 lon: 9.18951 facility: IRCCS Ospedale Galeazzi-Sant'Ambrogio city: Milan zip: 20161 country: Italy name: Ricardo Ciliberto, MD role: CONTACT email: rciliberto@gmail.com name: Laura role: CONTACT lat: 45.46427 lon: 9.18951 hasResults: False
nctId: NCT06287008 id: 2023-0085 briefTitle: ABO-Incompatible Kidney Transplants Between Robot-Assisted vs. Open Surgery overallStatus: COMPLETED date: 2020-10-01 date: 2023-09-30 date: 2024-01-31 date: 2024-02-29 date: 2024-03-01 name: Asan Medical Center class: OTHER briefSummary: While robot-assisted kidney transplantation (RAKT) offers potential benefits such as minimal postoperative pain, better cosmesis, fewer wound infections, and shorter hospital stay, its efficacy in ABO-incompatible (ABO-i) KT compared to open KT (OKT) remains understudied. This study aims to compare ABO-i KT outcomes between RAKT and OKT.
The study utilized data from 29 ABO-i RAKT and 210 ABO-i OKT cases performed at Asan Medical Center from October 2020 to February 2023. Univariate and multivariate analyses were performed to evaluate factors associated with a composite of biopsy-proven acute rejection (BPAR), de novo donor-specific antibodies (DSA), and overall graft failure. conditions: Kidney Transplantation studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: RETROSPECTIVE count: 239 type: ACTUAL name: robot-assisted kidney transplantation measure: Graft survival measure: renal function measure: . A composite of biopsy-proven acute rejection, graft failure, and the development of de novo donor-specific antibodies sex: ALL minimumAge: 18 Years maximumAge: 80 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Asan Medical Center city: Seoul zip: 05505 country: Korea, Republic of lat: 37.566 lon: 126.9784 hasResults: False
nctId: NCT06286995 id: 6280 briefTitle: Postoperative Pain Assessment After Canal Preparation by Different NiTi File Systems overallStatus: COMPLETED date: 2023-10-14 date: 2024-01-29 date: 2024-02-14 date: 2024-02-29 date: 2024-02-29 name: Ain Shams University class: OTHER briefSummary: The participants were divided into two groups : group one ( Trunatomy file group)(n=10) was mechanically prepared the canals by Trunatomy file and group two ( Edgeendo x7 file group) ( n=10) was prepared the canals by Edgeendo x7 file, the participants were assessed pain preoperatively and postoperatively by Visual Analog Scale(VAS) conditions: Post Operative Pain conditions: Inflammation studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: This study was designed to be randomized,single- blinded, single-center clinical trial primaryPurpose: TREATMENT masking: DOUBLE maskingDescription: A) Sequence generation: was done using random sequence number generated by computer software B) Allocation concealment Mechanism:folded,numbered papers were placed in tightly sealed envelopes containing patients' coding whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 20 type: ACTUAL name: Chemomechanical preparation for root canals measure: Level of post operative pain using 10-cm visual analogue scale ( VAS) measure: Level of inflammatory mediators substance P in apical fluid samples sex: ALL minimumAge: 20 Years maximumAge: 50 Years stdAges: ADULT facility: Ain Shams university city: Cairo country: Egypt lat: 30.06263 lon: 31.24967 hasResults: False
nctId: NCT06286982 id: OASIS III briefTitle: The Oral Symptom Assessment Scale in Older Patients With Frailty overallStatus: RECRUITING date: 2023-06-06 date: 2024-07-06 date: 2024-07-06 date: 2024-02-29 date: 2024-03-07 name: Our Lady's Hospice and Care Services class: OTHER briefSummary: Oral (or mouth) symptoms are common in older patients who live with frailty. It is known that frailty describes someone's overall resilience and how this relates to the chances of recovery following a health problem. A questionnaire called the Oral Symptom Assessment Scale (or OSAS) was designed to look at mouth symptoms in patients who had an advanced cancer. These symptoms may overlap with patients who have frailty.
This study will take place in Our Lady's Hospice \& Care Services, Harold's Cross and St James' Hospital over six months. conditions: Frailty conditions: Older Adults studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 250 type: ESTIMATED name: Oral Symptom Assessment Scale measure: To determine the prevalence of oral symptoms in older patients with frailty measure: To determine the clinical features of these oral symptoms in this group (i.e. frequency, severity and level of distress) measure: To determine the relationship between oral symptoms and Clinical Frailty Score / Cumulative Illness Rating Scale for Geriatrics/Medications measure: To provide initial validation of OSAS in older patients with frailty sex: ALL minimumAge: 65 Years stdAges: OLDER_ADULT facility: St James's Hospital status: RECRUITING city: Dublin zip: D8 country: Ireland name: Niamh Cleary, MB MICGP role: CONTACT phone: +353876603466 (Ireland) email: clearynm@tcd.ie name: Amanda Lavan, PhD MRCPI role: SUB_INVESTIGATOR name: Roman Romero Ortuno, MSc PhD MRCP role: SUB_INVESTIGATOR lat: 53.33306 lon: -6.24889 facility: Our Lady's Hospice and Care Services status: RECRUITING city: Dublin zip: Dublin 6W country: Ireland name: Niamh M Cleary, MB MICGP role: CONTACT phone: +353876603466 (Ireland) email: clearynm@tcd.ie name: Norah Fagan, RGN MSc role: SUB_INVESTIGATOR lat: 53.33306 lon: -6.24889 hasResults: False
nctId: NCT06286969 id: ZSLL-ZN-2024-007-01 briefTitle: Clinical Study on Intensive Multi-acupuncture in the Treatment of Lumbar Muscle Strain. overallStatus: NOT_YET_RECRUITING date: 2024-03-01 date: 2024-12-31 date: 2025-03-01 date: 2024-02-29 date: 2024-02-29 name: Xu Xinnan class: OTHER briefSummary: Acupuncture is widely used as a routine treatment for lumbar muscle strain. The aim of this randomized controlled trial is to evaluate the effectiveness of the intensive multi-acupuncture method. This trial will include 108 patients with lumbar muscle strain injury from two outpatient clinics. All participants will be randomized in a 1:1 ratio to the intensive multi-acupuncture method group and the normal needling group. Outcomes will be assessed before the intervention, after one treatment, after five treatments, and at follow-up 2 weeks after the end of treatment. The primary outcome indicator will be the clinical efficacy evaluation criteria, and the secondary outcome indicators will be the pain visual analog scale (VAS) score, the Japanese Orthopaedic Association Assessment Treatment Score (JOA) score, the lumbar joint mobility measurement scale, and the Modified Ashworth Grading Scale. This study will provide evidence as to whether the intensive multi-acupuncture method is safe and effective. conditions: Lumbar Muscle Strain studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 108 type: ESTIMATED name: acupuncture measure: clinical efficacy evaluation criteria measure: Pain visual analog scale (VAS) score measure: Japanese Orthopaedic Association Scores measure: Lumbar Joint Mobility Measurement Scale measure: Improvement of the Ashworth Rating Scale sex: ALL minimumAge: 18 Years maximumAge: 70 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False